Showing 281 - 300 results of 8,962 for search 'significantly ((((((lower decrease) OR (we decrease))) OR (teer decrease))) OR (larger decrease))', query time: 0.48s Refine Results
  1. 281
  2. 282
  3. 283

    Downregulation of <i>TcPiezo1</i> expression decreases Ca<sup>2+</sup> entry in <i>T. cruzi.</i> by Guozhong Huang (673424)

    Published 2025
    “…(B) Downregulation of <i>TcPiezo1</i> expression showed a significant decrease of intracellular Ca<sup>2+</sup> (+Tet). …”
  4. 284
  5. 285
  6. 286

    Sensitivity analysis. by Jiuming Li (11711375)

    Published 2025
    “…According to the follow-up, 271 (56.7%) were in the exclusive breastfeeding group and the rest in the non-exclusive breastfeeding group (n = 207, 43.3%). A significant decrease in exclusive breastfeeding rate was observed in the prolonged TTP group compared to the short TTP group (OR=0.46, 95% CI: 0.27–0.74). …”
  7. 287

    Characteristics of participants. by Jiuming Li (11711375)

    Published 2025
    “…According to the follow-up, 271 (56.7%) were in the exclusive breastfeeding group and the rest in the non-exclusive breastfeeding group (n = 207, 43.3%). A significant decrease in exclusive breastfeeding rate was observed in the prolonged TTP group compared to the short TTP group (OR=0.46, 95% CI: 0.27–0.74). …”
  8. 288

    Participant Flowchart. by Jiuming Li (11711375)

    Published 2025
    “…According to the follow-up, 271 (56.7%) were in the exclusive breastfeeding group and the rest in the non-exclusive breastfeeding group (n = 207, 43.3%). A significant decrease in exclusive breastfeeding rate was observed in the prolonged TTP group compared to the short TTP group (OR=0.46, 95% CI: 0.27–0.74). …”
  9. 289

    Stratified analyses. by Jiuming Li (11711375)

    Published 2025
    “…According to the follow-up, 271 (56.7%) were in the exclusive breastfeeding group and the rest in the non-exclusive breastfeeding group (n = 207, 43.3%). A significant decrease in exclusive breastfeeding rate was observed in the prolonged TTP group compared to the short TTP group (OR=0.46, 95% CI: 0.27–0.74). …”
  10. 290
  11. 291
  12. 292

    Flowchart of the screening process. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  13. 293

    Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  14. 294

    Characteristics of included reviews. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  15. 295

    Result of the PRISMA assessments. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  16. 296

    Result of the ROBIS assessments. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  17. 297
  18. 298
  19. 299
  20. 300